Overall, these results suggest a mild improvement in whole‐body insulin sensitivity in Asb2 MKO mice, although the augmented muscle mass was insufficient to counteract HFD‐induced obesity or glucose intolerance. The gene discussed is ASB2; the disease is obesity disorder.